These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 29059160)

  • 1. IL6 derived from cancer-associated fibroblasts promotes chemoresistance via CXCR7 in esophageal squamous cell carcinoma.
    Qiao Y; Zhang C; Li A; Wang D; Luo Z; Ping Y; Zhou B; Liu S; Li H; Yue D; Zhang Z; Chen X; Shen Z; Lian J; Li Y; Wang S; Li F; Huang L; Wang L; Zhang B; Yu J; Qin Z; Zhang Y
    Oncogene; 2018 Feb; 37(7):873-883. PubMed ID: 29059160
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cancer-associated fibroblasts mediated chemoresistance by a FOXO1/TGFβ1 signaling loop in esophageal squamous cell carcinoma.
    Zhang H; Xie C; Yue J; Jiang Z; Zhou R; Xie R; Wang Y; Wu S
    Mol Carcinog; 2017 Mar; 56(3):1150-1163. PubMed ID: 27769097
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Methylation decreases the Bin1 tumor suppressor in ESCC and restoration by decitabine inhibits the epithelial mesenchymal transition.
    Wang X; Wang J; Jia Y; Wang Y; Han X; Duan Y; Lv W; Ma M; Liu L
    Oncotarget; 2017 Mar; 8(12):19661-19673. PubMed ID: 28152502
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long non-coding RNA LINC00337 induces autophagy and chemoresistance to cisplatin in esophageal squamous cell carcinoma cells via upregulation of TPX2 by recruiting E2F4.
    Yang C; Shen S; Zheng X; Ye K; Ge H; Sun Y; Lu Y
    FASEB J; 2020 May; 34(5):6055-6069. PubMed ID: 32239565
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased expression of EIF5A2, via hypoxia or gene amplification, contributes to metastasis and angiogenesis of esophageal squamous cell carcinoma.
    Li Y; Fu L; Li JB; Qin Y; Zeng TT; Zhou J; Zeng ZL; Chen J; Cao TT; Ban X; Qian C; Cai Z; Xie D; Huang P; Guan XY
    Gastroenterology; 2014 Jun; 146(7):1701-13.e9. PubMed ID: 24561231
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The identification of the ATR inhibitor VE-822 as a therapeutic strategy for enhancing cisplatin chemosensitivity in esophageal squamous cell carcinoma.
    Shi Q; Shen LY; Dong B; Fu H; Kang XZ; Yang YB; Dai L; Yan WP; Xiong HC; Liang Z; Chen KN
    Cancer Lett; 2018 Sep; 432():56-68. PubMed ID: 29890208
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Msi2 plays a carcinogenic role in esophageal squamous cell carcinoma via regulation of the Wnt/β-catenin and Hedgehog signaling pathways.
    Li Z; Jin H; Mao G; Wu L; Guo Q
    Exp Cell Res; 2017 Dec; 361(1):170-177. PubMed ID: 29054489
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FAM3B promotes progression of oesophageal carcinoma via regulating the AKT-MDM2-p53 signalling axis and the epithelial-mesenchymal transition.
    He SL; Wang WP; Yang YS; Li EM; Xu LY; Chen LQ
    J Cell Mol Med; 2019 Feb; 23(2):1375-1385. PubMed ID: 30565387
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inflammatory CXCL12-CXCR4/CXCR7 axis mediates G-protein signaling pathway to influence the invasion and migration of nasopharyngeal carcinoma cells.
    Qiao N; Wang L; Wang T; Li H
    Tumour Biol; 2016 Jun; 37(6):8169-79. PubMed ID: 26715277
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DEPTOR suppresses the progression of esophageal squamous cell carcinoma and predicts poor prognosis.
    Ji YM; Zhou XF; Zhang J; Zheng X; Li SB; Wei ZQ; Liu T; Cheng DL; Liu P; Song K; Tan T; Zhu H; Guo JL
    Oncotarget; 2016 Mar; 7(12):14188-98. PubMed ID: 26893358
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhanced cancer stem cell properties of a mitotically quiescent subpopulation of p75NTR-positive cells in esophageal squamous cell carcinoma.
    Kojima H; Okumura T; Yamaguchi T; Miwa T; Shimada Y; Nagata T
    Int J Oncol; 2017 Jul; 51(1):49-62. PubMed ID: 28534989
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Significance of PI3K/AKT signaling pathway in metastasis of esophageal squamous cell carcinoma and its potential as a target for anti-metastasis therapy.
    Li B; Xu WW; Lam AKY; Wang Y; Hu HF; Guan XY; Qin YR; Saremi N; Tsao SW; He QY; Cheung ALM
    Oncotarget; 2017 Jun; 8(24):38755-38766. PubMed ID: 28418888
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The PSMD14 inhibitor Thiolutin as a novel therapeutic approach for esophageal squamous cell carcinoma through facilitating SNAIL degradation.
    Jing C; Li X; Zhou M; Zhang S; Lai Q; Liu D; Ye B; Li L; Wu Y; Li H; Yue K; Chen P; Yao X; Wu Y; Duan Y; Wang X
    Theranostics; 2021; 11(12):5847-5862. PubMed ID: 33897885
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cisplatin-activated PAI-1 secretion in the cancer-associated fibroblasts with paracrine effects promoting esophageal squamous cell carcinoma progression and causing chemoresistance.
    Che Y; Wang J; Li Y; Lu Z; Huang J; Sun S; Mao S; Lei Y; Zang R; Sun N; He J
    Cell Death Dis; 2018 Jul; 9(7):759. PubMed ID: 29988148
    [TBL] [Abstract][Full Text] [Related]  

  • 15. eIF4E promotes tumorigenesis and modulates chemosensitivity to cisplatin in esophageal squamous cell carcinoma.
    Liu T; Li R; Zhao H; Deng J; Long Y; Shuai MT; Li Q; Gu H; Chen YQ; Leng AM
    Oncotarget; 2016 Oct; 7(41):66851-66864. PubMed ID: 27588477
    [TBL] [Abstract][Full Text] [Related]  

  • 16. C-X-C motif chemokine 12/C-X-C chemokine receptor type 7 signaling regulates breast cancer growth and metastasis by modulating the tumor microenvironment.
    Wani N; Nasser MW; Ahirwar DK; Zhao H; Miao Z; Shilo K; Ganju RK
    Breast Cancer Res; 2014 May; 16(3):R54. PubMed ID: 24886617
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circular RNA circNTRK2 facilitates the progression of esophageal squamous cell carcinoma through up-regulating NRIP1 expression via miR-140-3p.
    Chen X; Jiang J; Zhao Y; Wang X; Zhang C; Zhuan L; Zhang D; Zheng Y
    J Exp Clin Cancer Res; 2020 Jul; 39(1):133. PubMed ID: 32653032
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting MCL-1 sensitizes human esophageal squamous cell carcinoma cells to cisplatin-induced apoptosis.
    Yu X; Li W; Xia Z; Xie L; Ma X; Liang Q; Liu L; Wang J; Zhou X; Yang Y; Liu H
    BMC Cancer; 2017 Jun; 17(1):449. PubMed ID: 28659182
    [TBL] [Abstract][Full Text] [Related]  

  • 19. BRCA1-Associated Protein Increases Invasiveness of Esophageal Squamous Cell Carcinoma.
    Zhao Y; Wei L; Shao M; Huang X; Chang J; Zheng J; Chu J; Cui Q; Peng L; Luo Y; Tan W; Tan W; Lin D; Wu C
    Gastroenterology; 2017 Nov; 153(5):1304-1319.e5. PubMed ID: 28780075
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Downregulation of MiR-31 stimulates expression of LATS2 via the hippo pathway and promotes epithelial-mesenchymal transition in esophageal squamous cell carcinoma.
    Gao Y; Yi J; Zhang K; Bai F; Feng B; Wang R; Chu X; Chen L; Song H
    J Exp Clin Cancer Res; 2017 Nov; 36(1):161. PubMed ID: 29145896
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.